Re: Middle East market…
I think someone here posted that recently, without the link. I went to the Insmed home page to read the article but there was not a PR from Insmed.
I had always been under the impression that in able to market a product in that region, the drug had to be approved in the United States. The article says taiba (apparently capitalization of company names isn't status quo over there) will be in charge once the region receives marketing authorization, so I'm not sure what that means, or how long it takes.
I could go ask on the Yahoo board, because they now have 8 traders, 3 physicians, and 2 biotech scientists for a total of 20??? Nah, I will wait for the Insmed PR.